1 Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Apr 11, 2025
Read More Hospital The sensational feeling channel in the world -- where there is perception, there is pain and happiness Mar 30, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Medical BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma Apr 12, 2025
